findmyKOL
Clinical trialNCT06765109RecruitingPhase 3Interventional

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

SponsorNuvalent Inc.Enrollment450Anaplastic Lymphoma Kinase-positiveNon-small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

155 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Sanatorio Parque S.A.

    Rosario, Santa Fe Province, Argentina

    Gaston Martinengo, M.D.
    Recruiting
  • Sanatorio Allende

    Córdoba, Argentina

    Ignacio Jerez, M.D.
    Recruiting
Australia
  • Westmead Hospital

    Westmead, New South Wales, Australia

    Pei Ding, MB BChir, Ph.D.
    Recruiting
  • Austin Health

    Heidelberg, Victoria, Australia

    Sagun Parakh, M.D.
    Recruiting
  • Peter Maccallum Cancer Centre

    Melbourne, Australia

    Benjamin Solomon, MBBS, Ph.D.
    Recruiting
Austria
  • Wiener Gesundheitsverbund

    Vienna, Austria

    Maximilian Hochmair, MD
    Recruiting
Belgium
  • Cliniques Universitaires Saint-Luc

    Brussels, Belgium

    Frank Aboubakar Nana, M.D., Ph.D.
    Recruiting
  • Antwerp University Hospital

    Edegem, Belgium

    Jo Raskin, M.D.
    Recruiting
  • Uz Leuven

    Leuven, Belgium

    Christophe Dooms, M.D., Ph.D.
    Recruiting
Brazil
  • Fundação Pio Xii

    Barretos, Brazil

    Josiane Mourao Dias, MD
    Recruiting
  • Santa Casa de Misericordia de Belo Horizonte

    Belo Horizonte, Brazil

    Gilson Gabriel Veloso, MD
    Recruiting
  • Hospital Sao Lucas Da Pontificia Universidade Catolica Do Rio Grande Do Sul

    Porto Alegre, Brazil

    Ana Caroline Gelatti, MD
    Recruiting
  • Irmandade Da Santa Casa de Misericordia de Porto Alegre

    Porto Alegre, Brazil

    Katsuki Tiscoski, MD
    Recruiting
  • Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base

    São José do Rio Preto, Brazil

    Joao Antonio Soler, MD
    Recruiting
  • A.C.Camargo Cancer Center

    São Paulo, Brazil

    Vladmir Cordeiro de Lima, Ph.D.
    Recruiting
  • Hospital Amaral Carvalho

    São Paulo, Brazil

    Patricia Medeiros Milhomem Beato, M.D.
    Recruiting
  • Instituto Do Cancer Do Estado de São Paulo Icesp

    São Paulo, Brazil

    Milena Mak, MD
    Recruiting
Canada
  • Princess Margaret Cancer Centre

    Toronto, Ontario, Canada

    Geoffrey Liu, M.D.
    Recruiting
Chile
  • Fundacion Arturo Lopez Perez Falp

    Providencia, Chile

    Christian Caglevic Medina, MD
    Recruiting
  • Centro de Investigaciones Clinicas Uc Cicuc

    Santiago, Chile

    Hector Gonzalo Galindo Aranibar, MD
    Recruiting
  • Centro de Oncologia de Precision de la Universidad Mayor

    Santiago, Chile

    Pamela Salman, MD
    Recruiting
  • Oncovida - Santiago

    Santiago, Chile

    Ariel Zwenger, MD
    Recruiting
Czechia
  • Nemocnice Agel Nový Jičín A.S.

    Nový Jičín, Czechia

    Vojtech Tlusty, MUDr.
    Recruiting
Denmark
  • Aarhus Universitetshospital

    Aarhus, Denmark

    Peter Meldgaard, MD
    Recruiting
  • Herlev and Gentofte Hospital

    Herlev, Denmark

    Rikke Andersen, M.D., Ph.D.
    Recruiting
  • University of Southern Denmark

    Odense, Denmark

    Lotte Holm Land, M.D., Ph.D.
    Recruiting
France
  • Centre Hospitalier Universitaire D' Angers

    Angers, France

    Youssef Oulkhouir, M.D.
    Recruiting
  • Institut Bergonie

    Bordeaux, France

    Sophie Cousin, M.D.
    Recruiting
  • Centre Francois Baclesse

    Caen, France

    Hubert Curcio, M.D.
    Recruiting
  • Centre Leon Berard

    Lyon, France

    Aurelie Swalduz, M.D.
    Recruiting
  • Hospital Nord

    Marseille, France

    Pascale Tomasini, M.D.
    Recruiting
  • Institut Regional Du Cancer de Montpellier

    Montpellier, France

    Xavier Quantin, M.D., Ph.D.
    Recruiting
  • Centre Hospitalier Universitaire (chu) Nantes Hopital Nord Laennec

    Nantes, France

    Elvire Pons-Tostivint, M.D., Ph.D.
    Recruiting
  • Aphp - Hôpital Tenon

    Paris, France

    Jacques Cadranel, MD
    Recruiting
  • Centre Hospitalier Universitaire (chu) de Bordeaux

    Pessac, France

    Remi Veillon, M.D.
    Recruiting
  • Centre Hospitalier Universitaire de Toulouse - Hopital Larrey

    Toulouse, France

    Julien Mazieres, M.D., Ph.D.
    Recruiting
Germany
  • Helios Klinikum Emil Von Behring Gmbh

    Berlin, Germany

    Jens Kollmeier, Dr. med.
    Recruiting
  • Klinikum Esslingen Gmbh

    Esslingen am Neckar, Germany

    Martin Faehling, PD M.D. MsC
    Recruiting
  • Lungenclinic Grosshansdorf Gmbh

    Großhansdorf, Germany

    Martin Reck, Prof, M.D.
    Recruiting
  • Lungenfachklinik Immenhausen

    Immenhausen, Germany

    Achim Rittmeyer, M.D.
    Recruiting
115 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AlectinibNeladalkib
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Jul 2025
Primary completion
31 Dec 2029
Completion
31 Dec 2029
Last update posted
2 Jun 2026
Registered enrollment
450
Registry id
NCT06765109

Cross-registrations

EU-CTR / CTIS (EudraCT)2024-517553-26

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.